Circulating microRNAs in blood of patients with prostate cancer;MicroARN circulantes en sangre de pacientes con cáncer de próstata

Actas Urologicas Espanolas

Volumn 38, Issue 10, 2014, Pages 633-639

  Medina Villaamil, V ^a   Martinez Breijo S ^a   Portela Pereira, P ^a   Quindos Varela M ^a   Santamarina Cainzos I ^a   Anton Aparicio L M ^a,b   Gomez Veiga F ^a  

^a CHU A Coruna   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Micrometastasis; MicroRNAs; Polymerase chain reaction; Prostate cancer

Indexed keywords

MICRORNA;

AGED; BLOOD; GENETICS; HUMAN; MALE; MIDDLE AGED; PROSTATE TUMOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 84922651987     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acuro.2014.02.008     Document Type: Article

References (28)

1. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:5-20.
2. Valladares-Ayerbes M, Reboredo M, Medina-Villaamil V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Haz M, et al. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med. 2012;10:186.
3. Chen X, Ba Y, Cai X, Yin Y, Wang K, Guo J, et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997-1006.
4. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513-8.
5. Brase JC, Johannes M, Schlomm T, Falth M, Haese A, Steuber T,et al. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer. 2011;128:608-16.
6. Selth LA, Townley S, Gillis JL, Ochnik AM, Murti K, Macfarlane RJ, et al. Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. Int J Cancer. 2012;131:652-61.
7. Bryant RJ, Pawlowski T, Catto JW, Marsden G, Vessella RL, Rhees B, et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer. 2012;106:768-74.
8. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36.
9. Kozomara A, Griffiths-Jones S. miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011;39(Database issue):D152-7.
10. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: Targets and expression. Nucleic Acids Res. 2008;36(Database issue):D149-53.
11. Yang Z, Ren F, Liu C, He S, Sun G, Gao Q, et al. dbDEMC: A database of differentially expressed miRNAs in human cancers. BMC Genomics. 2010;2 11 Suppl 4:S5.
12. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129:1401-14.
13. Zhang Y, Luoh SM, Hon LS, Baertsch R, Wood WI, Zhang Z. GeneHub-GEPIS: Digital expression profiling for normal and cancer tissues based on an integrated gene database. Nucleic Acids Res. 2007;35(Web Server issue):W152-8.
14. Bargaje R, Hariharan M, Scaria V, Pillai B. Consensus miRNA expression profiles derived from interplatform normalization of microarray data. RNA. 2010;16:16-25.
15. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, et al. TM4: A free, open-source system for microarray data management and analysis. Biotecniques. 2003;34:374.
16. Kral M, Rosinska V, Student V, Grepl M, Hrabec M, Bouchal J. Genetic determinants of prostate cancer: A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011;155:3-9.
17. Tomlins SA, Rhodes DR, Yu J, Varambally S, Mehra R, Perner S, et al. The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell. 2008;13:519-28.
18. Palanisamy N, Ateeq B, Kalyana-Sundaram S, Pflueger D, Ramnarayanan K, Shankar S, et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med. 2010;16:793-8.
19. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell. 2010;18:11-22.
20. Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: New prospects for old challenges. Genes Dev. 2010;24:1967-2000.
21. Gandellini P, Folini M, Zaffaroni N. Towards the definition of prostate cancer-related microRNAs: Where are we now? Trends Mol Med. 2009;15:381-90.
22. Schaefer A, Jung M, Kristiansen G, Lein M, Schrader M,Miller K, et al. Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp Mol Med. 2010;42:749-58.
23. Sun T, Wang Q, Balk S, Brown M, Lee M, Kantoff P.The role of microRNA 221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res. 2009;69:3356-63.
24. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science. 2008;322:1695-9.
25. Pang Y, Young CY, Yuan H. MicroRNAs and prostate cancer. Acta Biochim Biophys Sin (Shanghai). 2010;42:363-9.
26. Metias SM, Lianidou E, Yousef GM. MicroRNAs in clinical oncology: At the crossroads between promises and problems. J Clin Pathol. 2009;62:771-6.
27. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56:1733-41.
28. Chen ZH, Zhang GL, Li HR, Luo JD, Li ZX, Chen GM, et al. A panel of five circulating MicroRNAs as potential biomarkers for prostate cancer. Prostate. 2012;72:1443-52.